These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31107423)

  • 1. A Clinical Score to Support Antiretroviral Management of HIV-exposed Infants on the Day of Birth.
    Nesheim SR; Rose C; Pan Y; Mahle Gray K; Rao S; Singh S; Lampe M
    Pediatr Infect Dis J; 2019 Sep; 38(9):939-943. PubMed ID: 31107423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015.
    Williams PL; Huo Y; Rutstein R; Hazra R; Rough K; Van Dyke RB; Chadwick EG
    AIDS Patient Care STDS; 2018 Feb; 32(2):48-57. PubMed ID: 30346801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant outcomes after maternal antiretroviral exposure in resource-limited settings.
    Nielsen-Saines K; Komarow L; Cu-Uvin S; Jourdain G; Klingman KL; Shapiro DE; Mofenson L; Moran L; Campbell TB; Hitti J; Fiscus S; Currier J;
    Pediatrics; 2012 Jun; 129(6):e1525-32. PubMed ID: 22585772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mother-to-child HIV-transmission prevention programs in a sub-Saharan African setting: The Gabonese experience.
    Mintsa-Ndong A; Ndong-Ella C; Boussougou RK; Busugu LM; Mba A; Agwambouet FA; Barro N; Djoba Siawaya JF
    Int J STD AIDS; 2018 Mar; 29(3):221-226. PubMed ID: 28758568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatally acquired HIV-1 infection: prevention and evaluation of HIV-exposed infants.
    Shetty AK
    Semin Pediatr Infect Dis; 2005 Oct; 16(4):282-95. PubMed ID: 16210108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal Antiretroviral Exposure and Prevented Mother-to-child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.
    Little KM; Taylor AW; Borkowf CB; Mendoza MC; Lampe MA; Weidle PJ; Nesheim SR
    Pediatr Infect Dis J; 2017 Jan; 36(1):66-71. PubMed ID: 27749662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serological and nutritional outcome of infants born to HIV positive mothers undergoing option B + therapy in Guédiawaye].
    Baptiste DJ; Djibril D; Assane S; Ngagne M; Baly O; Ousmane N
    Pan Afr Med J; 2016; 25():224. PubMed ID: 28293340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples.
    Dunn DT; Simonds RJ; Bulterys M; Kalish LA; Moye J; de Maria A; Kind C; Rudin C; Denamur E; Krivine A; Loveday C; Newell ML
    AIDS; 2000 Jul; 14(10):1421-8. PubMed ID: 10930158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-nucleoside reverse transcriptase inhibitor levels among HIV-exposed uninfected infants at the time of HIV PCR testing - findings from a tertiary healthcare facility in Pretoria, South Africa.
    Mazanderani AH; Murray TY; Sherman GG; Snyman T; George J; Avenant T; Goga AE; Pepper MS; du Plessis N
    J Int AIDS Soc; 2019 Jun; 22(6):e25284. PubMed ID: 31215757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
    Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
    BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.